Incentive salience: novel treatment strategies for major depression
This article proposes that a recent shift in our understanding of dopamine function may support translational research to target deficits in positive emotions and reward processing in individuals with major depressive disorder (MDD). We review how dopamine functions to modulate approach behaviors in...
Gespeichert in:
Veröffentlicht in: | CNS spectrums 2013-12, Vol.18 (6), p.307-314 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 314 |
---|---|
container_issue | 6 |
container_start_page | 307 |
container_title | CNS spectrums |
container_volume | 18 |
creator | Soskin, David P. Holt, Daphne J. Sacco, Garret R. Fava, Maurizio |
description | This article proposes that a recent shift in our understanding of dopamine function may support translational research to target deficits in positive emotions and reward processing in individuals with major depressive disorder (MDD). We review how dopamine functions to modulate approach behaviors in response to positive incentives, and we describe the incentive salience hypothesis, which posits that dopamine primarily modulates “wanting,” or anticipatory reward, rather than “liking,” or subjective pleasure. Although the incentive salience hypothesis was first proposed to help explain how drugs of abuse may reinforce harmful behaviors in the absence of continued pleasure or “liking,” it may also provide a basis for understanding and developing new treatment approaches for MDD. Specifically, it provides a rationale for combining behaviorally activating psychotherapies and pro-dopaminergic agents to target impaired reward processing in MDD. |
doi_str_mv | 10.1017/S1092852913000345 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1465176067</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_S1092852913000345</cupid><sourcerecordid>2844766580</sourcerecordid><originalsourceid>FETCH-LOGICAL-c373t-97a0431134673dddc281d21215f25bafe8d1ebd952416501ed6715ece24d1c693</originalsourceid><addsrcrecordid>eNp1kE1Lw0AQhhdRbK3-AC8S8OIlurOfiTcpfhQKHtRz2GQnJSUfdTcp-O_d0KqgeNlhed95ZuYl5BzoNVDQNy9AU5ZIlgKnlHIhD8iUgZKxkjQ9JNNRjkd9Qk68X1MquE74MZkwnlJOmZ6S-aItsO2rLUbe1BWG323Udluso96h6ZsgRr53psdVhT4qOxc1Zh1eixuH3ldde0qOSlN7PNvXGXl7uH-dP8XL58fF_G4ZF1zzPk61CQsAcKE0t9YWLAHLgIEsmcxNiYkFzG0qmQg3UECrNEgskAkLhUr5jFztuBvXvQ_o-6ypfIF1bVrsBp-BUBK0ogE_I5e_rOtucG3YLmOJEFopmdDggp2rcJ33Dsts46rGuI8MaDYmnP1JOPRc7MlD3qD97viKNBj4Hmqa3FV2hT-z_8d-AvAZg9M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2844766580</pqid></control><display><type>article</type><title>Incentive salience: novel treatment strategies for major depression</title><source>MEDLINE</source><source>Cambridge University Press Journals Complete</source><creator>Soskin, David P. ; Holt, Daphne J. ; Sacco, Garret R. ; Fava, Maurizio</creator><creatorcontrib>Soskin, David P. ; Holt, Daphne J. ; Sacco, Garret R. ; Fava, Maurizio</creatorcontrib><description>This article proposes that a recent shift in our understanding of dopamine function may support translational research to target deficits in positive emotions and reward processing in individuals with major depressive disorder (MDD). We review how dopamine functions to modulate approach behaviors in response to positive incentives, and we describe the incentive salience hypothesis, which posits that dopamine primarily modulates “wanting,” or anticipatory reward, rather than “liking,” or subjective pleasure. Although the incentive salience hypothesis was first proposed to help explain how drugs of abuse may reinforce harmful behaviors in the absence of continued pleasure or “liking,” it may also provide a basis for understanding and developing new treatment approaches for MDD. Specifically, it provides a rationale for combining behaviorally activating psychotherapies and pro-dopaminergic agents to target impaired reward processing in MDD.</description><identifier>ISSN: 1092-8529</identifier><identifier>EISSN: 2165-6509</identifier><identifier>DOI: 10.1017/S1092852913000345</identifier><identifier>PMID: 23903027</identifier><language>eng</language><publisher>New York, USA: Cambridge University Press</publisher><subject>Amphetamines ; Animals ; Antidepressants ; Antidepressive Agents - therapeutic use ; Cognitive Therapy ; Depressive Disorder, Major - metabolism ; Depressive Disorder, Major - psychology ; Depressive Disorder, Major - therapy ; Dopamine ; Dopamine - metabolism ; Humans ; Hypotheses ; Kinases ; Mental depression ; Motivation ; Psychotropic drugs ; Review Articles ; Sucrose ; Tuberculosis</subject><ispartof>CNS spectrums, 2013-12, Vol.18 (6), p.307-314</ispartof><rights>Copyright © Cambridge University Press 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c373t-97a0431134673dddc281d21215f25bafe8d1ebd952416501ed6715ece24d1c693</citedby><cites>FETCH-LOGICAL-c373t-97a0431134673dddc281d21215f25bafe8d1ebd952416501ed6715ece24d1c693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S1092852913000345/type/journal_article$$EHTML$$P50$$Gcambridge$$H</linktohtml><link.rule.ids>164,314,780,784,27924,27925,55628</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23903027$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Soskin, David P.</creatorcontrib><creatorcontrib>Holt, Daphne J.</creatorcontrib><creatorcontrib>Sacco, Garret R.</creatorcontrib><creatorcontrib>Fava, Maurizio</creatorcontrib><title>Incentive salience: novel treatment strategies for major depression</title><title>CNS spectrums</title><addtitle>CNS Spectr</addtitle><description>This article proposes that a recent shift in our understanding of dopamine function may support translational research to target deficits in positive emotions and reward processing in individuals with major depressive disorder (MDD). We review how dopamine functions to modulate approach behaviors in response to positive incentives, and we describe the incentive salience hypothesis, which posits that dopamine primarily modulates “wanting,” or anticipatory reward, rather than “liking,” or subjective pleasure. Although the incentive salience hypothesis was first proposed to help explain how drugs of abuse may reinforce harmful behaviors in the absence of continued pleasure or “liking,” it may also provide a basis for understanding and developing new treatment approaches for MDD. Specifically, it provides a rationale for combining behaviorally activating psychotherapies and pro-dopaminergic agents to target impaired reward processing in MDD.</description><subject>Amphetamines</subject><subject>Animals</subject><subject>Antidepressants</subject><subject>Antidepressive Agents - therapeutic use</subject><subject>Cognitive Therapy</subject><subject>Depressive Disorder, Major - metabolism</subject><subject>Depressive Disorder, Major - psychology</subject><subject>Depressive Disorder, Major - therapy</subject><subject>Dopamine</subject><subject>Dopamine - metabolism</subject><subject>Humans</subject><subject>Hypotheses</subject><subject>Kinases</subject><subject>Mental depression</subject><subject>Motivation</subject><subject>Psychotropic drugs</subject><subject>Review Articles</subject><subject>Sucrose</subject><subject>Tuberculosis</subject><issn>1092-8529</issn><issn>2165-6509</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kE1Lw0AQhhdRbK3-AC8S8OIlurOfiTcpfhQKHtRz2GQnJSUfdTcp-O_d0KqgeNlhed95ZuYl5BzoNVDQNy9AU5ZIlgKnlHIhD8iUgZKxkjQ9JNNRjkd9Qk68X1MquE74MZkwnlJOmZ6S-aItsO2rLUbe1BWG323Udluso96h6ZsgRr53psdVhT4qOxc1Zh1eixuH3ldde0qOSlN7PNvXGXl7uH-dP8XL58fF_G4ZF1zzPk61CQsAcKE0t9YWLAHLgIEsmcxNiYkFzG0qmQg3UECrNEgskAkLhUr5jFztuBvXvQ_o-6ypfIF1bVrsBp-BUBK0ogE_I5e_rOtucG3YLmOJEFopmdDggp2rcJ33Dsts46rGuI8MaDYmnP1JOPRc7MlD3qD97viKNBj4Hmqa3FV2hT-z_8d-AvAZg9M</recordid><startdate>201312</startdate><enddate>201312</enddate><creator>Soskin, David P.</creator><creator>Holt, Daphne J.</creator><creator>Sacco, Garret R.</creator><creator>Fava, Maurizio</creator><general>Cambridge University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M2M</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>201312</creationdate><title>Incentive salience: novel treatment strategies for major depression</title><author>Soskin, David P. ; Holt, Daphne J. ; Sacco, Garret R. ; Fava, Maurizio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c373t-97a0431134673dddc281d21215f25bafe8d1ebd952416501ed6715ece24d1c693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Amphetamines</topic><topic>Animals</topic><topic>Antidepressants</topic><topic>Antidepressive Agents - therapeutic use</topic><topic>Cognitive Therapy</topic><topic>Depressive Disorder, Major - metabolism</topic><topic>Depressive Disorder, Major - psychology</topic><topic>Depressive Disorder, Major - therapy</topic><topic>Dopamine</topic><topic>Dopamine - metabolism</topic><topic>Humans</topic><topic>Hypotheses</topic><topic>Kinases</topic><topic>Mental depression</topic><topic>Motivation</topic><topic>Psychotropic drugs</topic><topic>Review Articles</topic><topic>Sucrose</topic><topic>Tuberculosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Soskin, David P.</creatorcontrib><creatorcontrib>Holt, Daphne J.</creatorcontrib><creatorcontrib>Sacco, Garret R.</creatorcontrib><creatorcontrib>Fava, Maurizio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Psychology Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>CNS spectrums</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Soskin, David P.</au><au>Holt, Daphne J.</au><au>Sacco, Garret R.</au><au>Fava, Maurizio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incentive salience: novel treatment strategies for major depression</atitle><jtitle>CNS spectrums</jtitle><addtitle>CNS Spectr</addtitle><date>2013-12</date><risdate>2013</risdate><volume>18</volume><issue>6</issue><spage>307</spage><epage>314</epage><pages>307-314</pages><issn>1092-8529</issn><eissn>2165-6509</eissn><abstract>This article proposes that a recent shift in our understanding of dopamine function may support translational research to target deficits in positive emotions and reward processing in individuals with major depressive disorder (MDD). We review how dopamine functions to modulate approach behaviors in response to positive incentives, and we describe the incentive salience hypothesis, which posits that dopamine primarily modulates “wanting,” or anticipatory reward, rather than “liking,” or subjective pleasure. Although the incentive salience hypothesis was first proposed to help explain how drugs of abuse may reinforce harmful behaviors in the absence of continued pleasure or “liking,” it may also provide a basis for understanding and developing new treatment approaches for MDD. Specifically, it provides a rationale for combining behaviorally activating psychotherapies and pro-dopaminergic agents to target impaired reward processing in MDD.</abstract><cop>New York, USA</cop><pub>Cambridge University Press</pub><pmid>23903027</pmid><doi>10.1017/S1092852913000345</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1092-8529 |
ispartof | CNS spectrums, 2013-12, Vol.18 (6), p.307-314 |
issn | 1092-8529 2165-6509 |
language | eng |
recordid | cdi_proquest_miscellaneous_1465176067 |
source | MEDLINE; Cambridge University Press Journals Complete |
subjects | Amphetamines Animals Antidepressants Antidepressive Agents - therapeutic use Cognitive Therapy Depressive Disorder, Major - metabolism Depressive Disorder, Major - psychology Depressive Disorder, Major - therapy Dopamine Dopamine - metabolism Humans Hypotheses Kinases Mental depression Motivation Psychotropic drugs Review Articles Sucrose Tuberculosis |
title | Incentive salience: novel treatment strategies for major depression |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T20%3A50%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incentive%20salience:%20novel%20treatment%20strategies%20for%20major%20depression&rft.jtitle=CNS%20spectrums&rft.au=Soskin,%20David%20P.&rft.date=2013-12&rft.volume=18&rft.issue=6&rft.spage=307&rft.epage=314&rft.pages=307-314&rft.issn=1092-8529&rft.eissn=2165-6509&rft_id=info:doi/10.1017/S1092852913000345&rft_dat=%3Cproquest_cross%3E2844766580%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2844766580&rft_id=info:pmid/23903027&rft_cupid=10_1017_S1092852913000345&rfr_iscdi=true |